1. FRI0316 The Efficacy and Safety of Subcutaneous Tocilizumab versus Intravenous Tocilizumab in Combination with Traditional DMARDS in Patients with RA at Week 97 (SUMMACTA). (10th June 2014) Authors: Burmester, G.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M.J.; Roane, G.; Ludivico, C.; Mysler, E.; Bennett, M.J.; Rowell, L.; Bao, M. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0029 Baricitinib, An Oral Janus Kinase (JAK)1/JAK2 Inhibitor, in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to TNF Inhibitors: Results of the Phase 3 RA-Beacon Study. (9th June 2015) Authors: Genovese, M.C.; Kremer, J.; Zamani, O.; Ludivico, C.; Krogulec, M.; Xie, L.; Beattie, S.; Koch, A.E.; Cardillo, T.; Rooney, T.; Macias, W.; Schlichting, D.; Smolen, J.S. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra. (23rd January 2014) Authors: Burmester, G. R.; Rubbert-Roth, A.; Cantagrel, A.; Hall, S.; Leszczynski, P.; Feldman, D.; Rangaraj, M. J.; Roane, G.; Ludivico, C.; Mysler, E.; Rowell, L.; Vranic, I. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗